We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Samsung

Develops, manufactures, and markets diagnostic products and solutions for IVD and point-of-care applications read more Featured Products: More products

Download Mobile App




Samsung NeuroLogica to Operate Digital Radiography and Ultrasound Business Under New Brand

By MedImaging International staff writers
Posted on 08 Mar 2022
Print article
Image: Boston Imaging to commercialize Samsung DR and US imaging products in USA (Photo courtesy of Boston Imaging)
Image: Boston Imaging to commercialize Samsung DR and US imaging products in USA (Photo courtesy of Boston Imaging)

NeuroLogica Corp., the U.S. healthcare subsidiary of Samsung (Suwon-si, South Korea), has announced that the company’s digital radiography and ultrasound (DR & US) business will operate under a new brand called Boston Imaging (Danvers, MA, USA).

Boston Imaging markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. Boston Imaging is the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. Boston Imaging’s growing portfolio of advanced medical technologies is used in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction and increase workflow efficiency.

“This is a momentous day for the company, as it will allow us even greater focus on our core expertise, providing the U.S. market with innovative, best-in-class Digital Radiography and Ultrasound imaging devices with Samsung healthcare technology at the core,” said David Legg, Vice President, Ultrasound and Digital Radiography, Boston Imaging. “As we continue gaining market leadership, this change will also allow Boston Imaging to have a more dedicated focus for growing the business.”

“The Samsung name is synonymous with industry-leading imaging technology,” said Legg. “In the healthcare imaging market, Samsung is the only true technology company that is now in healthcare imaging, while competitors come from industrial roots that have pursued healthcare as an add-on business. This company specializes in delivering exquisite imaging results.”

“Our new brand, Boston Imaging, reinforces the strength of our legacy and signals the potential of our future,” added Legg. “Our past advancements and achievements within the two modalities include the current introduction of innovative products such as the V8 Ultrasound system and artificial intelligence solutions, like Auto Lung Nodule Detection (ALND) tool, in Digital Radiography.”

“Boston Imaging’s team mission is improving patient care by developing outstanding, customer-centric imaging solutions quickly and with passion. We remain committed to our vision of making the world a healthier place by empowering clinicians to diagnose their patients more confidently, quickly and cost-effectively,” said Legg. “We will continue to maintain our normal business operations and operating structure. The legal entity and name of the company remains NeuroLogica Corp. We will be Doing Business As (DBA), Boston Imaging. The mobile computed tomography (CT) business will continue to operate under the existing company name, NeuroLogica.”

Related Links:
Samsung 
Boston Imaging 

New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Ultrasound Imaging System
P12 Elite
New
Digital Radiographic System
OMNERA 300M
New
Ultra-Flat DR Detector
meX+1717SCC

Print article
Radcal

Channels

Radiography

view channel
Image: The new X-ray detector produces a high-quality radiograph (Photo courtesy of ACS Central Science 2024, DOI: https://doi.org/10.1021/acscentsci.4c01296)

Highly Sensitive, Foldable Detector to Make X-Rays Safer

X-rays are widely used in diagnostic testing and industrial monitoring, from dental checkups to airport luggage scans. However, these high-energy rays emit ionizing radiation, which can pose risks after... Read more

MRI

view channel
Image: Artificial intelligence models can be trained to distinguish brain tumors from healthy tissue (Photo courtesy of 123RF)

AI Can Distinguish Brain Tumors from Healthy Tissue

Researchers have made significant advancements in artificial intelligence (AI) for medical applications. AI holds particular promise in radiology, where delays in processing medical images can often postpone... Read more

Nuclear Medicine

view channel
Image: Example of AI analysis of PET/CT images (Photo courtesy of Academic Radiology; DOI: 10.1016/j.acra.2024.08.043)

AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer

Immunotherapy has significantly advanced the treatment of primary lung cancer, but it can sometimes lead to a severe side effect known as interstitial lung disease. This condition is characterized by lung... Read more

General/Advanced Imaging

view channel
Image: Cleerly offers an AI-enabled CCTA solution for personalized, precise and measurable assessment of plaque, stenosis and ischemia (Photo courtesy of Cleerly)

AI-Enabled Plaque Assessments Help Cardiologists Identify High-Risk CAD Patients

Groundbreaking research has shown that a non-invasive, artificial intelligence (AI)-based analysis of cardiac computed tomography (CT) can predict severe heart-related events in patients exhibiting symptoms... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.